14-3-3 Protein, Spinal Fluid
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Supporting, in conjunction with other tests, a diagnosis of Creutzfeldt-Jakob disease in patients with rapidly progressive dementia when other neurodegenerative conditions have been excluded.
Immunochemiluminometric Assay (ICMA)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
14-3-3 Protein, CSF